Raising money to support Berwick resident Chloe French and her family was the motivation for a group of people to go into the ...

Maintaining healthy skin involves many practices, one of which is mole removal, a procedure increasingly popular for both cosmetic and health reasons.

Stephens Inc. AR reduced its stake in Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 4.3% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 14,439 shares ...

Danielle said she hopes to 'raise awareness' of the symptoms to look out for after receiving her own diagnosis - here's the ...

Bristol Myers Squibb announced the Phase 3 RELATIVITY-098 trial evaluating Opdualag (nivolumab and relatlimab-rmbw) for the adjuvant treatment of patients wi ...

H.C. Wainwright analyst Raghuram Selvaraju increased the price target on Replimune Group (NASDAQ:REPL), currently trading at $13.79 with a market cap of $1.06 billion, to $22.00, up from the previous ...

Leerink analyst Jonathan Chang raised the firm’s price target on Replimune (REPL) to $21 from $18 to reflect an increased probability of ...

Ideaya is financially strong, with $1.2 billion in cash reserves, sufficient to fund operations into at least 2028. Click ...

"The £1.4M raised by LFFM London will have a transformative impact on our mission," said Stephanie Kauffman, president of the Melanoma Research Alliance. "This generous support allows us to ...

raised its stake in Castle Biosciences by ... Barrett's esophagus, uveal melanoma, and mental health conditions. It offers DecisionDx-Melanoma, a risk stratification gene expression profile ...